Belimumab: A Guide to Its Use in Systemic Lupus Erythematosus

被引:0
作者
Lesley J. Scott
Celeste B. Burness
Paul L. McCormack
机构
[1] Adis,
来源
BioDrugs | 2012年 / 26卷
关键词
Systemic Lupus Erythematosus; Placebo Recipient; Infusion Reaction; Physical Component Summary Score; Belimumab;
D O I
暂无
中图分类号
学科分类号
摘要
Belimumab (Benlysta ®), a fully human recombinant IgG1λ monoclonal antibody that inhibits the binding of soluble B lymphocyte stimulator to B cells, is indicated for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity despite receiving standard therapy. In multinational trials, significantly more belimumab recipients than placebo recipients achieved an SLE Responder Index response at 52 weeks.
引用
收藏
页码:195 / 199
页数:4
相关论文
共 50 条
[41]   SPANISH NATIONAL REGISTRY OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS [J].
Laino, M. ;
Enguita, M. ;
Castaneda, S. ;
Loricera, J. ;
Moriano, C. ;
Lasa, C. ;
Calvo-Rio, V. ;
Narvaez, J. ;
Navarro Palomo, P. ;
Casafont-Sole, I. ;
Font, J. ;
Gallego, A. ;
Carrion Barbera, I. ;
Quiroga Colino, P. ;
Garcia-Aparicio, A. ;
Belzunegui Otano, J. M. ;
Lopez, M. ;
Jimenez de Aberasturi, J. R. De Dios ;
Hernandez, S. ;
Heredia, S. ;
Farina, A. ;
Navarro Blasco, F. J. ;
Ortega Castro, R. ;
Del Olmo Perez, L. ;
Labrador-Sanchez, E. ;
Pinillos, V. ;
Ortega de la O, M. C. ;
Castro, P. ;
Blanco, J. M. ;
Paulino Huertas, M. ;
Matias de la Mano, M. A. ;
Peralta-Gines, C. ;
Garcia-Cirera, S. ;
Camins, J. ;
Urruticoechea-Arana, A. ;
Medina Malone, M. ;
Cossio Jimenez, P. J. ;
Perez-Pampin, E. ;
Varas, B. ;
Vazquez, C. ;
Vegas-Revenga, N. ;
Rusinovich, O. ;
Giner, E. ;
Lamua-Riazuelo, J. R. ;
Aldasoro, V. .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :899-901
[42]   Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus [J].
Miyazaki, Yusuke ;
Nakayamada, Shingo ;
Sonomoto, Koshiro ;
Akio, Kawabe ;
Inoue, Yoshino ;
Okubo, Naoaki ;
Iwata, Shigeru ;
Hanami, Kentaro ;
Tanaka, Yoshiya .
RHEUMATOLOGY, 2022, 61 (09) :3614-3626
[43]   BUDGET IMPACT ANALYSIS OF BELIMUMAB IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS [J].
Pierotti, Francesca ;
Palla, Iaria ;
Pippo, Lara ;
Lorenzoni, Valentina ;
Turchetti, Giuseppe .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2016, 32 (05) :348-354
[44]   Efficacy and safety data of belimumab in patients with systemic lupus erythematosus [J].
Shakoory, Bita ;
Clatham, Winn .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (03) :159-164
[45]   Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus [J].
Struemper, Herbert ;
Chen, Cecil ;
Cai, Wendy .
JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (07) :711-720
[46]   Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association [J].
Shamriz, O. ;
Yahia, S. H. ;
Ramot, Y. ;
Agmon-Levin, N. ;
Tal, Y. .
LUPUS, 2020, 29 (04) :426-430
[47]   Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with belimumab [J].
Wei, Si-Ru ;
Zhu, Zhen-Zhen ;
Xu, Jia ;
Mo, Han-You .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) :154-156
[48]   BELIMUMAB INDUCES REMISSION OF DERMATOLOGIC MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS [J].
Athanassiou, P. ;
Katsavouni, C. ;
Tzanavari, A. ;
Banti, T. ;
Kalinou, C. ;
Kostoglou-Athanassiou, I. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) :S94-S94
[49]   Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain [J].
Cevey, Maria ;
Calvo-Alen, Jaime ;
Crespo, Carlos ;
Robles-Marhuenda, Angel ;
Smolen, Lee ;
Cortes-Hernandez, Josefina .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 :757-765
[50]   Belimumab in childhood systemic lupus erythematosus: A review of available data [J].
Chen, Feng ;
Zheng, Ying ;
Chen, Xinying ;
Wen, Zhanfa ;
Xu, Youjia ;
Yang, Jinghua ;
Xu, Kaisi .
FRONTIERS IN IMMUNOLOGY, 2022, 13